CClinicalTrials.gg
CompletedNCT04446481TUNeUpdated Oct 20, 2025

Neurofeedback to Aid Vets' Memory

An interventional study of Neurofeedback in Mild Cognitive Impairment, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-20.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Non-randomized
Ages
60 Years and older
Sex
All
01

Study summary

Military deployment is associated with increased risk of mild cognitive impairment (MCI). Combat stress related memory deficits has been well documented. Mild cognitive impairment such as memory deficits are the most common and earliest symptoms of Alzheimer's disease and related dementia (ADRD). The complaints about declined memory are common in healthy and cognitively intact civilian older adults, but less understood in aging Veterans. Brain training strategies to enhance cognitive skills and especially memory processes are unmet needs in aging Veterans who are at additional risk for MCI induced by ADRD. Since currently there is no effective drug treatment to stop cognitive decline, non-invasive brain training to boost memory functions in older Veterans is an increasingly attractive option to attenuating decline in memory.

Read the detailed description

The proposed project is poised to investigate state-of-art neurofeedback (NF; biofeedback of brain activity) training for self-modulation of neural plasticity to boost memory performance in Veterans. The recent advance of NF with Brian-Computer Interface (BCI) has provided a novel way to examine brain functions and plasticity. Thus far, there have been limited applications that have developed effective experimental and clinical paradigms for rehabilitation in Veterans. Historically, brainwave patterns during memory task performance have been analysed offline, a methodology which does not allow real-time NF modulation and training. The central hypothesis guiding this research is that optimal memory-related brainwave patterns of a Veteran can be trained. The online NF allows maximization of brainwave patterns associated with healthier memory states.

The development of efficient NF paradigms to augment memory performance is an important first step for the application of this nonpharmacologic intervention to improve combat Veterans' memory functions and potential for treating MCI due to mild TBI or pain. The pilot work will start with wider range of Veterans using state-of-the-art wearable wireless brain-computer interface headset, which is affordable and can be easily set up in VAMCs and eventually in remote assessment settings. This innovative, cognitive neuroscience based, nonpharmacologic intervention serves to revolutionize the diagnosis and treatment of combat Veterans who are at risk for degenerative dementia.

02

Conditions studied

  • Mild Cognitive Impairment

Keywords

  • neurofeedback
  • amnestic MCI
  • wireless EEG
  • Bluegrass Memory Test
  • working memory
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's enrollment of 4 is below the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Veterans age 60 and older

Exclusion criteria

Exclusion Criteria:

  • Veterans diagnosed with PTSD, epilepsy schizophrenia, or use benzodiazepines
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
4 participants (actual)

Study arms

  • Experimental
    MCI patients

    Vets with mild cognitive impairment

    Device: Neurofeedback

  • Active comparator
    NC

    Normal healthy Veterans

    Device: Neurofeedback

Interventions

  • DeviceNeurofeedback

    Neurofeedback will be tested in both groups of Vets

    Also known as: biofeedback

06

What researchers measure

Primary outcomes

  1. EEG alpha band

    alpha power under eyes closed and eyes open are linked to better mental state; likely biomarker for mild cognitive impairment.

    Time frame: 6-8 weeks

Secondary outcomes

  1. memory-related potentials

    Brainwaves that are linked to better memory performance

    Time frame: 6-8 weeks

  2. California Verbal Learning Test

    A battery of neuropsychological testing cognitive functions

    Time frame: About 6-8 weeks

07

Study locations

1 site
  • Lexington VA Medical Center, Lexington, KY
    Lexington, Kentucky 40502-2235, United States
08

References and documents

Publications

  • Jiang Y, Jessee W, Hoyng S, Borhani S, Liu Z, Zhao X, Price LK, High W, Suhl J, Cerel-Suhl S. Sharpening Working Memory With Real-Time Electrophysiological Brain Signals: Which Neurofeedback Paradigms Work? Front Aging Neurosci. 2022 Mar 28;14:780817. doi: 10.3389/fnagi.2022.780817. eCollection 2022. PubMed 35418848 ↗
  • Jiang Y, Neal J, Sompol P, Yener G, Arakaki X, Norris CM, Farina FR, Ibanez A, Lopez S, Al-Ezzi A, Kavcic V, Guntekin B, Babiloni C, Hajos M. Parallel electrophysiological abnormalities due to COVID-19 infection and to Alzheimer's disease and related dementia. Alzheimers Dement. 2024 Oct;20(10):7296-7319. doi: 10.1002/alz.14089. Epub 2024 Aug 29. PubMed 39206795 ↗

Study documents

  • Informed consent form · Apr 19, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — De-identified data will be analyzed and kept at least 6 years after project. Results will be shared via publications. The qualified researchers may contact PI and VA for further sharing of the research data.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04446481
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Jun 25, 2020
Start date
Feb 5, 2022
Primary completion
Sep 30, 2025
Completion
Sep 30, 2025
Last update
Oct 20, 2025

Study contacts

Yang Jiang, PhD
principal investigator · Lexington VA Medical Center, Lexington, KY

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion